Publication | Open Access
Pretreatment with antibiotics is associated with reduced therapeutic response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma
17
Citations
35
References
2023
Year
Prior ATB use was associated with reduced therapeutic responses in patients with HCC receiving atezolizumab plus bevacizumab.
| Year | Citations | |
|---|---|---|
Page 1
Page 1